SynAI: an AI-driven cancer drugs synergism prediction platform

SUMMARY: The SynAI solution is a flexible AI-driven drug synergism prediction solution aiming to discover potential therapeutic value of compounds in early stage. Rather than providing a finite choice of drug combination or cell lines, SynAI is capable of predicting potential drug synergism/antagoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Kuan, Jia, Runjun, Guo, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660295/
https://www.ncbi.nlm.nih.gov/pubmed/38023331
http://dx.doi.org/10.1093/bioadv/vbad160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660295/
https://www.ncbi.nlm.nih.gov/pubmed/38023331
http://dx.doi.org/10.1093/bioadv/vbad160

Ejemplares similares